{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:30:40Z","timestamp":1787761840749,"version":"build-2784847793"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Upper eyelid retraction (UER) is the most common sign of thyroid eye disease (TED) and may result in lagophthalmos and exposure keratopathy. Measures to address UER are varied and include conservative treatment, surgical intervention, and injections of botulinum toxin, hyaluronic acid (HA) filler, and triamcinolone acetonide (TA). Our article will discuss the various nonsurgical aspects of managing TED-related UER, focusing on the injections of botulinum toxin, HA filler, and TA to the upper eyelid, which have all been reported to be effective in improving UER in both active and inactive states of TED. Individual response may vary, and repeated injections may be necessary.<\/jats:p>","DOI":"10.4103\/tjo.tjo-d-23-00043","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T08:02:21Z","timestamp":1684310541000},"page":"548-553","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Nonsurgical management of upper eyelid retraction in thyroid eye disease"],"prefix":"10.4103","volume":"14","author":[{"given":"Stephanie Ming","family":"Young","sequence":"first","affiliation":[{"name":"Eagle Eye Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Duck","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Nune Eye Hospital, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung In","family":"Woo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"R1-20241220","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","article-title":"Clinical features of Grave's ophthalmopathy in an incidence cohort","volume":"121","author":"Bartley","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R2-20241220","first-page":"216","article-title":"Lid retraction and levator aponeurosis defects in Grave's eye disease","volume":"17","author":"Frueh","year":"1986","journal-title":"Ophthalmic Surg"},{"key":"R3-20241220","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo.82.7.773","article-title":"Development of a disease specific quality of life questionnaire for patients with Grave's ophthalmopathy: The GO-QOL","volume":"82","author":"Terwee","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"R4-20241220","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/eye.2011.359","article-title":"Assessing Grave's ophthalmopathy-specific quality of life in Korean patients","volume":"26","author":"Choi","year":"2012","journal-title":"Eye (Lond)"},{"key":"R5-20241220","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0161-6420(81)34987-2","article-title":"Surgical treatment of thyroid-related upper eyelid retraction. Graded M\u00fcller's muscle excision and levator recession","volume":"88","author":"Putterman","year":"1981","journal-title":"Ophthalmology"},{"key":"R6-20241220","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajo.2005.02.034","article-title":"Transconjunctival M\u00fcller muscle recession with levator disinsertion for correction of eyelid retraction associated with thyroid-related orbitopathy","volume":"140","author":"Ben Simon","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R7-20241220","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/01676830.2011.604897","article-title":"Stability of eyelid height after graded anterior-approach lid lowering for dysthyroid upper lid retraction","volume":"30","author":"Shortt","year":"2011","journal-title":"Orbit"},{"key":"R8-20241220","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.IOP.0000129529.36577.5B","article-title":"Pre-Whitnall levator recession with hang-back sutures in Graves orbitopathy","volume":"20","author":"McNab","year":"2004","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R9-20241220","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0161-6420(81)80002-4","article-title":"The use of sclera in the treatment of dysthyroid eyelid retraction","volume":"88","author":"Doxanas","year":"1981","journal-title":"Ophthalmology"},{"issue":"(Pt 4)","key":"R10-20241220","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/eye.1989.57","article-title":"The surgical management of dysthyroid related eyelid retraction using Mersilene mesh","volume":"3","author":"Downes","year":"1989","journal-title":"Eye (Lond)"},{"key":"R11-20241220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archopht.122.1.55","article-title":"Graded full-thickness anterior blepharotomy for upper eyelid retraction","volume":"122","author":"Elner","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R12-20241220","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/bjo.2004.052852","article-title":"Full thickness eyelid transsection (blepharotomy) for upper eyelid lengthening in lid retraction associated with Grave's disease","volume":"89","author":"Hintschich","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R13-20241220","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/ICU.0b013e3283499433","article-title":"A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease","volume":"22","author":"Kazim","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"key":"R14-20241220","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/eye.2013.160","article-title":"Turn-over orbital septal flap and levator recession for upper-eyelid retraction secondary to thyroid eye disease","volume":"27","author":"Watanabe","year":"2013","journal-title":"Eye (Lond)"},{"key":"R15-20241220","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/SAP.0000000000000656","article-title":"Modified full thickness graded blepharotomy for upper eyelid retraction associated with thyroid eye disease in East Asians","volume":"77","author":"Lee","year":"2016","journal-title":"Ann Plast Surg"},{"key":"R16-20241220","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1034\/j.1600-0420.2001.790608.x","article-title":"Thyroid associated ophthalmopathy: Botulinum toxin A in the treatment of upper eyelid retraction \u2013A pilot study","volume":"79","author":"Tr\u00e4isk","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"key":"R17-20241220","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/01676830903324268","article-title":"Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease","volume":"29","author":"Salour","year":"2010","journal-title":"Orbit"},{"key":"R18-20241220","first-page":"258","article-title":"Botulinum toxin type A in upper lid retraction of Grave's ophthalmopathy","volume":"13","author":"Ebner","year":"1993","journal-title":"J Clin Neuroophthalmol"},{"key":"R19-20241220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00002341-200405000-00001","article-title":"Botulinum toxin type a for dysthyroid upper eyelid retraction","volume":"20","author":"Morgenstern","year":"2004","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R20-20241220","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000310837","article-title":"Chemodenervation in treatment of upper eyelid retraction","volume":"211","author":"Ozkan","year":"1997","journal-title":"Ophthalmologica"},{"key":"R21-20241220","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0161-6420(02)01041-2","article-title":"Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection","volume":"109","author":"Uddin","year":"2002","journal-title":"Ophthalmology"},{"key":"R22-20241220","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.eye.6700690","article-title":"A single transcutaneous injection with Botox for dysthyroid lid retraction","volume":"18","author":"Shih","year":"2004","journal-title":"Eye (Lond)"},{"key":"R23-20241220","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/eye.2008.165","article-title":"Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage","volume":"23","author":"Costa","year":"2009","journal-title":"Eye (Lond)"},{"key":"R24-20241220","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/01676830.2020.1814351","article-title":"An algorithm for Botulinum toxin A injection for upper eyelid retraction associated with thyroid eye disease: Long-term results","volume":"40","author":"Ozturk Karabulut","year":"2021","journal-title":"Orbit"},{"key":"R25-20241220","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/IOP.0000000000000130","article-title":"Hyaluronic acid gel injection for upper eyelid retraction in thyroid eye disease: Functional and dynamic high-resolution ultrasound evaluation","volume":"30","author":"Kohn","year":"2014","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R26-20241220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IOP.0b013e3181c2a16d","article-title":"Nonsurgical management of upper eyelid margin asymmetry using hyaluronic acid gel filler","volume":"27","author":"Mancini","year":"2011","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R27-20241220","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.eye.6702933","article-title":"Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: A case series","volume":"22","author":"Chee","year":"2008","journal-title":"Eye (Lond)"},{"key":"R28-20241220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jcjo.2011.12.005","article-title":"Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy","volume":"47","author":"Xu","year":"2012","journal-title":"Can J Ophthalmol"},{"key":"R29-20241220","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00417-012-2153-y","article-title":"Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections","volume":"251","author":"Lee","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R30-20241220","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1097\/SCS.0b013e3182646043","article-title":"Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease","volume":"23","author":"Lee","year":"2012","journal-title":"J Craniofac Surg"},{"key":"R31-20241220","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00417-015-2957-7","article-title":"Fornix triamcinolone injection for thyroid orbitopathy","volume":"253","author":"Hamed-Azzam","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R32-20241220","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ceo.12939","article-title":"Peri-levator palpebrae superioris triamcinolone injection for the treatment of thyroid eye disease-associated upper eyelid retraction","volume":"45","author":"Joos","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"key":"R33-20241220","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/IOP.0000000000001120","article-title":"Transconjunctival triamcinolone injection for upper lid retraction in thyroid eye disease-a new injection method","volume":"34","author":"Young","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R34-20241220","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/01676830.2016.1193546","article-title":"The success rate of TED upper eyelid retraction reoperations","volume":"35","author":"Golan","year":"2016","journal-title":"Orbit"},{"key":"R35-20241220","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0002-9394(14)72787-4","article-title":"Diagnostic criteria for Grave's ophthalmopathy","volume":"119","author":"Bartley","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R36-20241220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.survophthal.2012.02.007","article-title":"Graves upper eyelid retraction","volume":"58","author":"Cruz","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"R37-20241220","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0161-6420(89)32874-0","article-title":"Enlargement of levator palpebrae superioris muscle fibers in Grave's ophthalmopathy","volume":"96","author":"Small","year":"1989","journal-title":"Ophthalmology"},{"key":"R38-20241220","first-page":"34","article-title":"Upper eyelid retraction from inferior rectus restriction in dysthyroid orbit disease","volume":"19","author":"Wesley","year":"1987","journal-title":"Ann Ophthalmol"},{"key":"R39-20241220","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0161-6420(94)38033-X","article-title":"Fixation duress in the pathogenesis of upper eyelid retraction in thyroid orbitopathy. A prospective study","volume":"101","author":"Hamed","year":"1994","journal-title":"Ophthalmology"},{"key":"R40-20241220","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jc.2005-1877","article-title":"Molecular pathology of Muller's muscle in Graves' ophthalmopathy","volume":"91","author":"Shih","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R41-20241220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00002341-200207000-00011","article-title":"Effect of hyperthyroidism on the orbicularis oculi muscle in rabbits","volume":"18","author":"Harrison","year":"2002","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R42-20241220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00002341-200201000-00003","article-title":"Clinicopathologic evaluation of the Mueller muscle in thyroid-associated orbitopathy","volume":"18","author":"Cockerham","year":"2002","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R43-20241220","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0094-1298(20)30403-X","article-title":"Cosmetic correction of eyelid deformities associated with exophthalmos","volume":"8","author":"Smith","year":"1981","journal-title":"Clin Plast Surg"},{"key":"R44-20241220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40618-016-0555-0","article-title":"Natural course of mild Grave's orbitopathy: Is it a chronic remitting or a transient disease?","volume":"40","author":"Anagnostis","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"R45-20241220","first-page":"444","article-title":"Prevalence and natural history of Grave's orbitopathy in the XXI century","volume":"36","author":"Piantanida","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"R46-20241220","first-page":"113","article-title":"Ocular changes in Grave's disease. A long-term follow-up study","volume":"29","author":"Hales","year":"1960","journal-title":"Q J Med"},{"key":"R47-20241220","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archinte.1960.00270170013003","article-title":"The endocrine eye lesion in hyperthyroidism. Its incidence and course in 165 patients treated for thyrotoxicosis with iodine","volume":"105","author":"Hamilton","year":"1960","journal-title":"Arch Intern Med"},{"key":"R48-20241220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jcem-25-1-1","article-title":"Management of thyrotoxicosis in patients with ophthalmopathy: Antithyroid regimen determined primarily by ocular manifestations","volume":"25","author":"Aranow","year":"1965","journal-title":"J Clin Endocrinol Metab"},{"key":"R49-20241220","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.0954-6820.1979.tb06012.x","article-title":"The course of endocrine ophthalmopathy during antithyroid therapy in a prospective study","volume":"205","author":"Solem","year":"1979","journal-title":"Acta Med Scand"},{"key":"R50-20241220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2265.1987.tb00848.x","article-title":"Prevalence, natural history and surgical treatment of exophthalmos","volume":"27","author":"Streeten","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R51-20241220","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/bjophthalmol-2018-313578","article-title":"Course of upper eyelid retraction in thyroid eye disease","volume":"104","author":"Lee","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R52-20241220","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archopht.1966.03850010366012","article-title":"Topical guanethidine therapy for endocrine lid retraction","volume":"76","author":"Gay","year":"1966","journal-title":"Arch Ophthalmol"},{"key":"R53-20241220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bjo.53.4.239","article-title":"Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction","volume":"53","author":"Cant","year":"1969","journal-title":"Br J Ophthalmol"},{"issue":"(Pt 1)","key":"R54-20241220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/eye.1988.5","article-title":"Clostridium botulinum toxins: Nature and preparation for clinical use","volume":"2","author":"Melling","year":"1988","journal-title":"Eye (Lond)"},{"key":"R55-20241220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00839203","article-title":"The management of blepharospasm and hemifacial spasm","volume":"239","author":"Elston","year":"1992","journal-title":"J Neurol"},{"issue":"(Pt 1)","key":"R56-20241220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/eye.1988.6","article-title":"Botulinum toxin therapy for squint","volume":"2","author":"Lee","year":"1988","journal-title":"Eye (Lond)"},{"key":"R57-20241220","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3928\/0191-3913-19940901-03","article-title":"Results of a prospective randomized trial of botulinum toxin therapy in acute unilateral sixth nerve palsy","volume":"31","author":"Lee","year":"1994","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"(Pt 4)","key":"R58-20241220","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/eye.1992.79","article-title":"Management of VIth nerve palsy--avoiding unnecessary surgery","volume":"6","author":"Riordan-Eva","year":"1992","journal-title":"Eye (Lond)"},{"key":"R59-20241220","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/archopht.1994.01090220070025","article-title":"Treatment of acquired nystagmus with botulinum neurotoxin A","volume":"112","author":"Repka","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"(Pt 4)","key":"R60-20241220","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/eye.1997.128","article-title":"Botulinum toxin for the temporary treatment of involutional lower lid entropion: A clinical and morphological study","volume":"11","author":"Steel","year":"1997","journal-title":"Eye (Lond)"},{"key":"R61-20241220","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0161-6420(86)33520-6","article-title":"Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm","volume":"93","author":"Burns","year":"1986","journal-title":"Ophthalmology"},{"key":"R62-20241220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0161-6420(88)33163-5","article-title":"Botulinum toxin A-induced protective ptosis in corneal disease","volume":"95","author":"Kirkness","year":"1988","journal-title":"Ophthalmology"},{"issue":"(Pt 5)","key":"R63-20241220","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/eye.1987.93","article-title":"Botulinum toxin A induced protective ptosis","volume":"1","author":"Adams","year":"1987","journal-title":"Eye (Lond)"},{"key":"R64-20241220","first-page":"924","article-title":"Pharmacologic weakening of extraocular muscles","volume":"12","author":"Scott","year":"1973","journal-title":"Invest Ophthalmol"},{"key":"R65-20241220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00140912","article-title":"Injection treatment of endocrine orbital myopathy","volume":"58","author":"Scott","year":"1984","journal-title":"Doc Ophthalmol"},{"key":"R66-20241220","first-page":"186","article-title":"Control of eyelid retraction associated with Grave's disease with botulinum A toxin","volume":"25","author":"Biglan","year":"1994","journal-title":"Ophthalmic Surg"},{"issue":"(Pt 5)","key":"R67-20241220","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/eye.1994.127","article-title":"Persisting hypotropias following protective ptosis induced by botulinum neurotoxin","volume":"8","author":"Heyworth","year":"1994","journal-title":"Eye (Lond)"},{"key":"R68-20241220","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00042737-200105000-00024","article-title":"Indications and efficacy of botulinum toxin in disorders of the gastrointestinal tract","volume":"13","author":"Mandal","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R69-20241220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00045391-200203000-00010","article-title":"Treatment of achalasia with botulinum A toxin","volume":"9","author":"da Silveira","year":"2002","journal-title":"Am J Ther"},{"key":"R70-20241220","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s003830100583","article-title":"The treatment of internal anal sphincter achalasia with botulinum toxin","volume":"17","author":"Messineo","year":"2001","journal-title":"Pediatr Surg Int"},{"key":"R71-20241220","first-page":"1","article-title":"Hyaluronic acid gel injection for dysthyroid upper eyelid retraction in Asian patients","volume":"9","author":"Young","year":"2022","journal-title":"Orbit"},{"key":"R72-20241220","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-0031-1298785","article-title":"Hyaluronic acid fillers: History and overview","volume":"27","author":"Kim","year":"2011","journal-title":"Facial Plast Surg"},{"key":"R73-20241220","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/01.prs.0000299382.31856.d8","article-title":"Nonsurgical treatment of cicatricial ectropion with hyaluronic acid filler","volume":"121","author":"Fezza","year":"2008","journal-title":"Plast Reconstr Surg"},{"key":"R74-20241220","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.iop.0000235820.00633.61","article-title":"Filling the periorbital hollows with hyaluronic acid gel: Initial experience with 244 injections","volume":"22","author":"Goldberg","year":"2006","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R75-20241220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/IOP.0b013e318192568d","article-title":"Use of hyaluronic Acid gel in the management of paralytic lagophthalmos: the hyaluronic Acid gel \u201cgold weight\u201d","volume":"25","author":"Mancini","year":"2009","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R76-20241220","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/IOP.0b013e3181ac984b","article-title":"Nonsurgical management of congenital eyelid malpositions using hyaluronic Acid gel","volume":"25","author":"Taban","year":"2009","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R77-20241220","first-page":"38","article-title":"Use of hyaluronic acid fillers to correct scleral show: A review of technique","volume":"11","author":"Bravo","year":"2018","journal-title":"J Clin Aesthet Dermatol"},{"key":"R78-20241220","article-title":"Non-surgical treatment for eyelid retraction in thyroid eye disease (TED)","author":"Grisolia","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"R79-20241220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1473-2165.2012.00622.x","article-title":"Restylane persisting in lower eyelids for 5 years","volume":"11","author":"Dayan","year":"2012","journal-title":"J Cosmet Dermatol"},{"key":"R80-20241220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Grave's orbitopathy guidelines for the management of Grave's Orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"R81-20241220","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0733-8635(18)30318-8","article-title":"Ocular effects of topical and systemic steroids","volume":"10","author":"Renfro","year":"1992","journal-title":"Dermatol Clin"},{"key":"R82-20241220","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.eye.6702667","article-title":"Steroid-induced ptosis: Case studies and histopathologic analysis","volume":"22","author":"Song","year":"2008","journal-title":"Eye (Lond)"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-23-00043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:08:32Z","timestamp":1787760512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-23-00043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-23-00043","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"2023-03-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}